CompaniesMontai Health

Montai Health

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (24)
View all

Total Trials

24

As Lead Sponsor

2

As Collaborator

22

Total Enrollment

3,549

By Phase

NA: 6PHASE4: 6PHASE2/PHASE3: 2PHASE2: 3PHASE1/PHASE2: 1PHASE1: 2

By Status

COMPLETED: 9RECRUITING: 6UNKNOWN: 5NOT_YET_RECRUITING: 2WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
NCT03087110
NCT04641013
NCT03413189
NCT03844113
NCT04113993
NCT04821544
NCT05182931
NCT05400616
NCT06543433
NCT06882499
Hover over trial bars to see details

Recent Trials

NCT06882499Collaborator
Stereotactic Ablative Body Radiotherapy (SABR) with Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
NANot yet recruiting
74 participants
Started: May 1, 2025 · Completed: Feb 29, 2032
NCT06962371Collaborator
Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)
NARecruiting
30 participants
Started: Apr 7, 2025 · Completed: Mar 31, 2026
NCT05770622Collaborator
Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
PHASE4Recruiting
40 participants
Started: Nov 10, 2024 · Completed: Jul 31, 2026
NCT06543433Collaborator
Skincubator, a Novel Incubator for Skin to Skin Contact Feasibility Study
PHASE2/PHASE3Not yet recruiting
50 participants
Started: Aug 31, 2024 · Completed: Sep 1, 2027
NCT05382494Collaborator
Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children
PHASE4Completed
130 participants
Started: Dec 5, 2022 · Completed: Jul 17, 2025
View all 24 trials →